Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine reply

被引：0
|
作者：
Lehtinen, Matti [1 ]
机构：
[1] Univ Tampere, Sch Publ Hlth, FIN-33101 Tampere, Finland
来源：
LANCET ONCOLOGY | 2012年 / 13卷 / 02期
关键词：
D O I：
10.1016/S1470-2045(12)70055-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E50 / E50
页数：1
相关论文
共 50 条
  • [31] Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
    Lehtinen, Matti
    Paavonen, Jorma
    Wheeler, Cosette M.
    Jaisamrarn, Unnop
    Garland, Suzanne M.
    Castellsague, Xavier
    Skinner, S. Rachel
    Apter, Dan
    Naud, Paulo
    Salmeron, Jorge
    Chow, Song-Nan
    Kitchener, Henry
    Teixeira, Julio C.
    Hedrick, James
    Limson, Genara
    Szarewski, Anne
    Romanowski, Barbara
    Aoki, Fred Y.
    Schwarz, Tino F.
    Poppe, Willy A. J.
    De Carvalho, Newton S.
    Germar, Maria Julieta V.
    Peters, Klaus
    Mindel, Adrian
    De Sutter, Philippe
    Xavier Bosch, F.
    David, Marie-Pierre
    Descamps, Dominique
    Struyf, Frank
    Dubin, Gary
    [J]. LANCET ONCOLOGY, 2012, 13 (01): : 89 - 99
  • [32] Molecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens in Cervarix™, the AS04-adjuvanted HPV-16 and-18 cervical cancer vaccine
    Deschuyteneer, Michel
    Elouahabi, Abdelatif
    Plainchamp, Dominique
    Plisnier, Michel
    Soete, Dominique
    Corazza, Yvon
    Lockman, Laurence
    Giannini, Sandra
    Deschamps, Marguerite
    [J]. HUMAN VACCINES, 2010, 6 (05): : 407 - 419
  • [33] Efficacy of Human Papillomavirus 16 and 18 (HPV-16/18) AS04-Adjuvanted Vaccine against Cervical Infection and Precancer in Young Women: Final Event-Driven Analysis of the Randomized, Double-Blind PATRICIA Trial
    Apter, Dan
    Wheeler, Cosette M.
    Paavonen, Jorma
    Castellsague, Xavier
    Garland, Suzanne M.
    Skinner, S. Rachel
    Naud, Paulo
    Salmeron, Jorge
    Chow, Song-Nan
    Kitchener, Henry C.
    Teixeira, Julio C.
    Jaisamram, Unnop
    Limson, Genara
    Szarewski, Anne
    Romanowski, Barbara
    Aoki, Fred Y.
    Schwarz, Tino F.
    Poppe, Willy A. J.
    Xavier Bosch, F.
    Mindel, Adrian
    De Sutter, Philippe
    Hardt, Karin
    Zahaf, Toufik
    Descamps, Dominique
    Struyf, Frank
    Lehtinen, Matti
    Dubin, Gary
    [J]. CLINICAL AND VACCINE IMMUNOLOGY, 2015, 22 (04) : 361 - 373
  • [34] Prevalence and Incidence of Human Papillomavirus (HPV) Infection Before and After Pregnancy: Pooled Analysis of the Control Arms of Efficacy Trials of HPV-16/18 AS04-Adjuvanted Vaccine (vol 6, ofz486, 2019)
    Chen, Jing
    Gopala, Kusuma
    Puthatta, Akarsh
    Struyf, Frank
    Rosillon, Dominique
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (03):
  • [35] Efficacy of Human Papillomavirus Type 16/18 AS04-Adjuvanted Vaccine in Japanese Women Aged 20 to 25 Years
    Konno, Ryo
    Tamura, Shinobu
    Dobbelaere, Kurt
    Yoshikawa, Hiroyuki
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 (05) : 847 - 855
  • [36] 2-Dose Schedule of AS04-Adjuvanted Human Papillomavirus Types 16/18 Vaccine
    Poddighe, Dimitri
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2017, 216 (06): : 782 - 783
  • [37] AS04-adjuvanted human papillomavirus types 16/18 vaccine (Cervarix®): A guide to its use
    Lyseng-Williamson K.A.
    McKeage K.
    [J]. Drugs & Therapy Perspectives, 2012, 28 (3) : 1 - 6
  • [38] Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese girls and women aged 9 to 45 years Results from 2 randomized controlled trials
    Zhu, Fengcai
    Li, Juan
    Hu, Yuemei
    Zhang, Xiang
    Yang, Xiaoping
    Zhao, Hui
    Wang, Junzhi
    Yang, Jianguo
    Xia, Guodong
    Dai, Qinyong
    Tang, Haiwen
    Suryakiran, Pemmaraju
    Datta, Sanjoy K.
    Descamps, Dominique
    Bi, Dan
    Struyf, Frank
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (07) : 1795 - 1806
  • [39] Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine in HIV-positive women in South Africa: A partially-blind randomised placebo-controlled study
    Denny, Lynette
    Hendricks, Bronwyn
    Gordon, Chivaugn
    Thomas, Florence
    Hezareh, Marjan
    Dobbelaere, Kurt
    Durand, Christelle
    Herve, Caroline
    Descamps, Dominique
    [J]. VACCINE, 2013, 31 (48) : 5745 - 5753
  • [40] Bivalent AS04-adjuvanted HPV vaccine provides optimal cancer prevention for HPV types not included in the vaccine
    Beyer, Walter E. P.
    Osterhaus, Albert D. M. E.
    [J]. VACCINE, 2020, 38 (47) : 7414 - 7416
12345